General Information
Revision date
2020-05-20
Product name
Oritavancin diphosphate
1.2.1 Relevant identified uses
For laboratory research purposes Not for drug or household use
Manufacturer Name
BioVision, Inc
Icons in SDS
Company Information
company name
BioVision, Inc
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Product Name/Chemical Name CAS Number EC-No. MW Chemical Formula Concentration Oritavancin diphosphate 192564-14-0 -- 1989.09 C₈₆H₉₇Cl₃N₁₀O₂₆ • 2H₃PO₄ 100% Oritavancin diphosphate Emergency Overview
2.1 Classification of the substance or mixture
Skin sensitisation (Sub-category 1A), H317
Signal word
Warning
Hazard statements
H317 May cause an allergic skin reaction.
Precautionary statements
P261 Avoid breathing dust/ fume/ gas/ mist/ vapours/ spray. P272 Contaminated work clothing should not be allowed out of the workplace. P280 Wear protective gloves. P302 + P352 IF ON SKIN: Wash with plenty of soap and water. P333 + P313 If skin irritation or rash occurs: Get medical advice/ attention. P363 Wash contaminated clothing before reuse. P501 Dispose of contents/ container to an approved waste disposal plant.
Health hazards
1 Flammability: 0 2 Fire: 0 Reactivity Hazard: 0
Physical hazards
0
Potential health effects
Inhalation: May be harmful if inhaled. Causes respiratory tract irritation. Skin: May be harmful if absorbed through skin. Causes skin irritation. Eyes: Causes eye irritation. Ingestion: Harmful if swallowed.
